Infrequent detectable somatic mutations of the RET and glial cell line- derived neurotrophic factor (GDNF) genes in human pituitary adenomas

Endocrine Journal

Volumn 46, Issue 1, 1999, Pages 199-207

  Yoshimoto, Katsuhiko ^a   Tanaka, Chisato ^a   Moritani, Maki ^a   Shimizu, Eiji ^a   Yamaoka, Takashi ^a   Yamada, Shozo ^b   Sano, Toshiaki ^a   Itakura, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Expression; Glial cell line derived neurotrophic factor (GDNF) gene; Mutations; Pituitary adenomas; RET proto oncogene

Indexed keywords

NEUROTROPHIC FACTOR;

ARTICLE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; SOMATIC MUTATION; TUMOR CELL CULTURE;

EID: 0032926652     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.46.199     Document Type: Article

References (26)

1. Eng C (1996) The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung disease. N Engl J Med 335: 943-951.
2. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A (1996) Characterization of a multicomponent receptor for GDNF. Nature 382: 80-83.
3. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryans AM, Caver-Moore K, Rosental A (1996) Renal and neuronal abnormalities in nice lacking GDNF. Nature 382: 76-79.
4. Angrist M, Bolk S, Halushka M, Lapchak PA, Chakravarti A (1996) Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nature Genet 14: 341-344.
5. Klein RD, Sherman D, Ho W-H, Stone D, Bennet GL, Moffat B, Vandlen R, Simmons L, Gu Q, Hongo J-A, Devaux B, Poulsen K, Armanini M, Nozaki C, Asai N, Goddard A, Phillips H, Henderson CE, Takahashi M, Rosenthal A (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387: 717-721.
6. Suvanto P, Hiltunen JO, Arumäe U, Moshnyakov M, Sariola H, Sanio K, Saarma M (1996) Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. Eur J Neurosci 8: 816-822.
7. Santoro M, Rosati R, Grieco M, Berlingieri MT, D'Amato GLC, de Fransisis V, Fusco A (1990) The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5: 1595-1598.
8. Nagao M, Ishizaka Y, Nakagawa A, Kohno K, Kuwano M, Tahira T, Ito F, Ikeda I, Sugimura T (1990) Expression of ret proto-oncogene in human neuroblastoma. Jpn J Cancer Res 81: 309-312.
9. Pachnis V, Mankoo B, Costantini F (1993) Expression of the ret proto-oncogene during mouse embryogenesis. Development 119: 1005-1017.
10. Komminoth P, Roth J, Maletta-Feuer S, Saremaslani P, Seelentag WKF, Heitz PU (1996) RET protooncogene point mutations in sporadic neuroendocrine tumors. J Clin Endocrinol Metab 81: 2041-2046.
11. Futami H, Egawa S, Tsukada T, Maruyama K, Bandoh S, Noguchi M, Yamaguchi K (1995) A novel somatic point mutation of the RET proto-oncogene in tumor tissues of small cell lung cancer patients. Jpn J Cancer Res 86: 1127-1130.
12. Hofstra RMW, Cheng NC, Hansen C, Stulp RP, Stelwagen T, Clausen N, Tommweup N, Caron H, Westerveld A, Versteeg R, Buys CHCM (1996) No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma. Hum Genet 97: 362-364.
13. Sano T, Ohshima T, Yamada S (1991) Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas. Path Res Prac 187: 530-533.
14. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Saito S, Itakura M (1992) Role of p53 mutations in endocrine tumorigenesis: Mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res 52: 5061-5064.
15. kipl gene and trisomy in a subset of human pituitary adenomas. J Clin Endocrinol Metab 82: 3141-3147.
16. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanatephenol-chloroform extraction. Anal Biochem 162: 156-159.
17. Takahashi M, Asai N, Iwashita T, Isomura T, Miyazaki K, Matsuyama M (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8: 2925-2929.
18. Trupp M, Rydén M, Jörnvall H, Funakoshi H, Timmusk T, Arenas E, Ibáñez CF (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 130: 137-148.
19. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267: 381-383.
20. Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the ret protooncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15: 1613-1619.
21. Hayashi K, Yandell DW (1993) How sensitive is PCR-SSCP? Hum Mutat 2: 338-346.
22. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogens 10: 191-198.
23. Kimura T, Yoshimoto K, Tanaka C, Ohkura T, Iwahana H, Miyauchi A, Sano T, Itakura M (1996) Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Eur J Endocrinol 134: 314-319.
24. Dahia PLM, Toledo SPA, Mulligan LM, Maher ER, Grossman AB, Eng C (1997) Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for RET/GDNF receptor a complex, in sporadic phaeochromocytomas. Cancer Res 57: 310-313.
25. Marsh DJ, Zheng Z, Arnold A, Andrew SD, Learoyd D, Frilling A, Komminoth P, Neuman HPH, Ponder PAJ, Rollins BJ, Shapiro GI, Robinson BG, Mulligan LM, Eng C (1997) Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors. J Clin Endocrinol Metab 82: 3025-3028.
26. Mulligan LM, Timmer T, Ivanchuk SM, Campling BG, Young LC, Rabbitts PH, Sundaresan V, Hofstra RMW, Eng C (1998) Investigation of the genes for RET and its ligand complex GDNF/GFRα-1, in small cell lung carcinoma. Genes Chromosomes Cancer 21: 326-332.